Zobrazeno 1 - 10
of 291
pro vyhledávání: '"Wolenski FS"'
Autor:
Mosedale M; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, 27599, United States. Electronic address: merrie@unc.edu., Cai Y; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, United States. Electronic address: ywcai@email.unc.edu., Eaddy JS; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, 27599, United States. Electronic address: jseaddy@gmail.com., Kirby PJ; Takeda Pharmaceuticals International Co., Cambridge, MA, 02139, United States. Electronic address: patrick.kirby@dragonflytx.com., Wolenski FS; Takeda Pharmaceuticals International Co., Cambridge, MA, 02139, United States. Electronic address: fwolenski@gmail.com., Dragan Y; Takeda Pharmaceuticals International Co., Cambridge, MA, 02139, United States. Electronic address: yvonne.dragan@takeda.com., Valdar W; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, United States; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, United States. Electronic address: william.valdar@unc.edu.
Publikováno v:
Toxicology [Toxicology] 2021 Sep; Vol. 461, pp. 152902. Date of Electronic Publication: 2021 Aug 18.
Autor:
Holmes, Grace1 (AUTHOR), Ferguson, Sophie R.2 (AUTHOR), Lewis, Patrick Alfryn1,3 (AUTHOR) plewis@rvc.ac.uk, Echeverri, Karen2 (AUTHOR) kecheverri@mbl.edu
Publikováno v:
Neural Development. 8/8/2024, Vol. 19 Issue 1, p1-11. 11p.
Autor:
Longo DM; DILIsym Services, Inc., Research Triangle Park, North Carolina 27709., Woodhead JL; DILIsym Services, Inc., Research Triangle Park, North Carolina 27709., Walker P; Cyprotex, Inc., Macclesfield SK10 4TG, UK., Herédi-Szabó K; SOLVO Biotechnology, Szeged 6728, Hungary., Mogyorósi K; SOLVO Biotechnology, Szeged 6728, Hungary., Wolenski FS; Takeda Pharmaceuticals International, Inc., Cambridge, Massachusetts 02139., Dragan YP; Takeda Pharmaceuticals International, Inc., Cambridge, Massachusetts 02139., Mosedale M; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.; UNC Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709., Siler SQ; DILIsym Services, Inc., Research Triangle Park, North Carolina 27709., Watkins PB; DILIsym Services, Inc., Research Triangle Park, North Carolina 27709.; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.; UNC Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709., Howell BA; DILIsym Services, Inc., Research Triangle Park, North Carolina 27709.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2019 Feb 01; Vol. 167 (2), pp. 458-467.
Autor:
Wolenski FS; Drug Safety Research and Evaluation, Takeda Pharmaceuticals International Co., Cambridge, MA, USA., Xia CQ; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., 35 Landsdowne Street, Cambridge, MA, USA., Ma B; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., 35 Landsdowne Street, Cambridge, MA, USA., Han TH; Seattle Genetics Inc., Bothell, WA, USA., Shyu WC; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., 35 Landsdowne Street, Cambridge, MA, USA., Balani SK; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., 35 Landsdowne Street, Cambridge, MA, USA. suresh.balani@takeda.com.
Publikováno v:
European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2018 Jun; Vol. 43 (3), pp. 347-354.
Autor:
Lin, Che-Yi1 (AUTHOR), Marlétaz, Ferdinand2 (AUTHOR), Pérez-Posada, Alberto3,4 (AUTHOR), Martínez-García, Pedro Manuel3 (AUTHOR), Schloissnig, Siegfried5 (AUTHOR), Peluso, Paul6 (AUTHOR), Conception, Greg T.6 (AUTHOR), Bump, Paul7 (AUTHOR), Chen, Yi-Chih1 (AUTHOR), Chou, Cindy1 (AUTHOR), Lin, Ching-Yi1 (AUTHOR), Fan, Tzu-Pei1 (AUTHOR), Tsai, Chang-Tai1 (AUTHOR), Gómez Skarmeta, José Luis3 (AUTHOR), Tena, Juan J.3 (AUTHOR), Lowe, Christopher J.7,8 (AUTHOR), Rank, David R.6 (AUTHOR), Rokhsar, Daniel S.8,9,10 (AUTHOR) dsrokhsar@gmail.com, Yu Jr, Kai1,11 (AUTHOR) dsrokhsar@gmail.com, Su, Yi-Hsien1 (AUTHOR) dsrokhsar@gmail.com
Publikováno v:
PLoS Biology. 6/3/2024, Vol. 22 Issue 6, p1-32. 32p.
Autor:
Webster, Nicole B.1,2 (AUTHOR), Meyer, Néva P.1 (AUTHOR) nmeyer@clarku.edu
Publikováno v:
Neural Development. 5/2/2024, Vol. 19, p1-18. 18p.
Autor:
Herui Li1,2,3,4, Yiming Ma1,2,3,4, Tiao Li1,2,3,4, Zihang Zeng1,2,3,4, Lijuan Luo1,2,3,4, Xiangming Liu1,2,3,4, Yi Li5, Yan Chen1,2,3,4 chenyan99727@csu.edu.cn
Publikováno v:
Tobacco Induced Diseases. Apr2024, Vol. 22, p1-10. 10p.
Autor:
Wolenski FS; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Zhu AZX; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Johnson M; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Yu S; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Moriya Y; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan., Ebihara T; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan., Csizmadia V; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Grieves J; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Paton M; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Liao M; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Gemski C; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Pan L; Takeda Pharmaceuticals International Co, Deerfield, Illinois, USA., Vakilynejad M; Takeda Pharmaceuticals International Co, Deerfield, Illinois, USA., Dragan YP; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Chowdhury SK; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Kirby PJ; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2017 May 01; Vol. 157 (1), pp. 50-61.
Autor:
Wolenski FS; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Shah P; Molecular Pathology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Sano T; Drug Safety Research Laboratories, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, 251-8555, Japan., Shinozawa T; Drug Safety Research Laboratories, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, 251-8555, Japan., Bernard H; Molecular Pathology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Gallacher MJ; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Wyllie SD; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Varrone G; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Cicia LA; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Carsillo ME; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Fisher CD; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Ottinger SE; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Koenig E; Molecular Pathology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Kirby PJ; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA.
Publikováno v:
Journal of applied toxicology : JAT [J Appl Toxicol] 2017 Mar; Vol. 37 (3), pp. 278-286. Date of Electronic Publication: 2016 Jul 11.
Autor:
Cole, Alison G.1,2 (AUTHOR) alison.cole@univie.ac.at, Steger, Julia1 (AUTHOR), Hagauer, Julia1 (AUTHOR), Denner, Andreas1 (AUTHOR), Ferrer Murguia, Patricio1 (AUTHOR), Knabl, Paul1 (AUTHOR), Narayanaswamy, Sanjay1 (AUTHOR), Wick, Brittney3 (AUTHOR), Montenegro, Juan D.1 (AUTHOR), Technau, Ulrich1,2,4 (AUTHOR) ulrich.technau@univie.ac.at
Publikováno v:
Frontiers in Zoology. 3/18/2024, Vol. 21 Issue 1, p1-17. 17p.